ReGeneraTing Agents (rgta®) technology combined with antibiotics improves outcomes for infections in the upper limb

ReGeneraTing Agents (rgta®) technology combined with antibiotics improves outcomes for infections in the upper limb

A matrix therapy agent marketed as CACIPLIQ20® showed marked improvement in the healing rate of hand infections, including functional recovery. It can be used at both earlier and later stages to promote faster healing and prevent an adverse outcome. A matrix therapy agent marketed as CACIPLIQ20® sho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical case reports 2021-03, Vol.9 (3), p.1083-1091
Hauptverfasser: Roohi, Sharifah Ahmad, Keuylian, Zela, Barritault, Denis
Format: Artikel
Sprache:eng
Schlagworte:
Abscesses
Amputation
Antibiotics
Binding sites
CACIPLIQ20
Case Report
Case Reports
Debridement
Diabetes
Extracellular matrix
Growth factors
Heparan sulfate
heparan sulfate mimetic
infection
Infections
matrix therapy
Orthopedics
Peptides
Proteins
Range of motion
Trauma
wound healing
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A matrix therapy agent marketed as CACIPLIQ20® showed marked improvement in the healing rate of hand infections, including functional recovery. It can be used at both earlier and later stages to promote faster healing and prevent an adverse outcome. A matrix therapy agent marketed as CACIPLIQ20® showed marked improvement in the healing rate of hand infections, including functional recovery. It can be used at both earlier and later stages to promote faster healing and prevent an adverse outcome.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.3645